Newtyn Management, LLC

Holdings History for Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH)

Symbol: TBPH on Nasdaq
Investment type: Equity - Shares of Stock
Class: Ordinary Share $0.00001 par value
Latest Disclosed Ownership: 4.76M shares
Security Ownership: 9.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Newtyn Management, LLC ownership in Theravance Biopharma, Inc. Ordinary Share $0.00001 par value (TBPH)

2025-02-14 - Newtyn Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.76M shares of Theravance Biopharma, Inc. Ordinary Share $0.00001 par value (TBPH). This represents 9.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Newtyn Management, LLC	9.7%		$44.9M	4.76M			$9.44	13G/A	12/31/2024	14 Feb 2025 16:05:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	7.8%	+0.42%	$44.8M	4.76M	+258,337	+5.74%	$9.41	Q4 2024
9/30/2024	5.57%	+2.94%	$36.3M	4.5M	+2,374,363	+112%	$8.06	Q3 2024
6/30/2024	3.38%	+0.81%	$18M	2.12M	+480,773	+29.2%	$8.48	Q2 2024
3/31/2024	2.94%	-0.45%	$14.7M	1.64M	-256,070	-13.5%	$8.97	Q1 2024
12/31/2023	4.19%	+0.16%	$21.4M	1.9M	+58,440	+3.17%	$11.24	Q4 2023
9/30/2023	3.92%	+0.43%	$15.9M	1.84M	+201,104	+12.3%	$8.63	Q3 2023
6/30/2023	4.01%	+0.27%	$17M	1.64M	+109,441	+7.15%	$10.35	Q2 2023
3/31/2023	3.26%	+0.17%	$16.6M	1.53M	+81,015	+5.59%	$10.85	Q1 2023
12/31/2022	3.36%	-2.42%	$16.3M	1.45M	-1,045,860	-41.9%	$11.22	Q4 2022
9/30/2022	5.56%	+1.02%	$25.3M	2.5M	+458,035	+22.5%	$10.14	Q3 2022
6/30/2022	3.5%	+1.14%	$18.5M	2.04M	+662,825	+48.2%	$9.06	Q2 2022
3/31/2022	3.15%	+0.86%	$13.1M	1.38M	+375,000	+37.5%	$9.56	Q1 2022
12/31/2021	2.93%	+2.65%	$11.1M	1M	+902,045	+921%	$11.05	Q4 2021
9/30/2021	0.19%	+0.2%	$725K	98K	+97,955	NEW	$7.40	Q3 2021
3/31/2020		-0.41%	$0	0	-173,300	-100%		Q1 2020
12/31/2019	0.41%	+0.26%	$4.49M	173K	+109,619	+172%	$25.89	Q4 2019
9/30/2019	0.12%	+0.12%	$1.24M	63.7K	+63,681	NEW	$19.49	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.